A lot of psychiatric follow-ups go like this: the provider asks how you’re doing, you say better or about the same, they renew the prescription, and you’re out in fifteen minutes.
If the medication isn’t really working, nobody catches it. If it’s half working, nobody adjusts it. The appointment happens but the monitoring doesn’t.
That’s a problem because psychiatric medications don’t work or not work in a clean binary.
There’s a whole spectrum between nothing changed and fully resolved, and where someone sits on that spectrum determines what needs to happen next. You can’t see where someone sits without actually measuring.
‘I Feel a Bit Better’ Isn’t a Data Point
Patients who improve partially are the ones who get missed most often.
Things are better than they were, so nobody flags it, and the medication stays unchanged for years while the person lives at sixty or seventy percent of where they could be with a dose adjustment or a different medication entirely.
Clinically there’s a real difference between partial response, full response, and remission. Partial means symptoms dropped but are still interfering with daily life.
Full means they’ve dropped enough that the person is actually functioning better.
Remission means the condition is essentially quiet. A provider working from general impressions can’t tell these apart. A provider using a rating scale at every visit can.
What Scales Like the PHQ-9 Actually Do
The PHQ-9 is a nine-item scale assessing how a patient has felt over the past two weeks, scored from 0 to 27.
A score of eighteen going down to nine between visits is a clinically meaningful drop even if the patient comes in saying they still feel pretty low. Depression distorts self-assessment.
The condition makes it hard to notice your own improvement because feeling at 50 percent becomes the new normal and gets reported as not much different.
The GAD-7 does the same for anxiety over seven items. The PCL-5 tracks PTSD symptoms across twenty. These aren’t paperwork.
They’re the mechanism by which a follow-up becomes something other than a conversation that tells the provider whatever mood the patient walked in with.
Side effects get tracked separately. Weight, sleep, appetite, sexual function, cognitive sharpness.
Patients almost never raise these unprompted, either because they assume it’s not relevant or because they don’t want to make the appointment complicated.
But unmanaged side effects are the main reason people quietly stop taking medications that were actually helping them.
Functioning and Symptoms Don’t Always Move Together
Someone’s PHQ-9 can drop from eighteen to nine and they’re still not leaving the house, still calling in sick, still canceling on everyone they know.
The symptom score improved. The person’s life didn’t. A follow-up that only looks at symptoms misses that completely.
Functioning measures ask about work, daily tasks, relationships, self-care. They fill in what the symptom score leaves out.
Two patients with the same PHQ-9 score can be in completely different places depending on whether their functioning recovered alongside their mood.
The clinical decision for each of them should probably be different.
When the Numbers and the Patient Say Different Things
Patient comes in saying about the same as last time. PHQ-9 went from nineteen to eight. That’s not a small change.
The scale caught something real that the patient’s own experience hasn’t registered yet.
Patient comes in saying much better. GAD-7 barely moved. Two panic attacks since the last visit.
That gap tells you something. Maybe the medication is helping sleep but not touching the anxiety.
Maybe there’s something happening in the patient’s life that isn’t being mentioned. Either way the discrepancy is a clinical signal that a general check-in wouldn’t surface at all.
Timing Is Everything
Most antidepressants need four to six weeks to reach stable levels and eight to twelve weeks before anyone can confidently say whether it’s working.
A two-week follow-up tells you about side effects. It tells you nothing about efficacy.
Providers who adjust medications at two weeks because the patient reports no improvement yet are working from data that was never going to show improvement yet.
Spacing visits too far out creates the opposite problem. A partial response sits unaddressed for months. Side effects the patient is quietly managing become the reason they stop taking it.
The monitoring is what makes the medication work, not just the prescription.
Medcanvas Psychiatry
At Medcanvas Psychiatry, follow-up visits aren’t just prescription renewals.
Rating scales every visit, side effect review built into every appointment, functioning tracked alongside symptoms, and medication decisions tied to what the data shows rather than how the conversation went. Patients aged 6 to 70 seen in Minot, North Dakota, in-person and by telepsychiatry.
If your follow-ups have mostly felt like quick check-ins, it might be time to find out what an objective one looks like.
Phone – 701-963-6917 | 701-857-1333
Email – contact-us@medcanvaspsychiatry.com
Location – 104 20th Ave., SW Ste. 4, Minot, ND 58701
Website – medcanvaspsychiatry.com
